Dr Girard is currently an Associate Professor at the Duke-NUS Medical School, and Principal Investigator I at the Singapore Eye Research Institute (SERI) where he heads the Ophthalmic Engineering & Innovation Laboratory (OEIL), and co-heads the Bioengineering & Devices Research Group. Dr Girard has strong expertise in Ophthalmic Engineering with a focus on Artificial Intelligence, Biomedical Imaging, Ocular Biomechanics, and Ophthalmic Devices. His research has especially focused on optic neuropathies (including glaucoma), but also myopia, corneal disorders, and cataract. Dr Girard’s research has remained translational, and he is the founder of the Singapore start-up company Abyss Processing Pte Ltd, that provides 3D AI solutions to simplify and improve glaucoma diagnosis & prognosis. Dr Girard has authored 120+ papers in top Ophthalmology and Engineering journals, has given 50+ invited talks, has received 30+ research grants & 20+ research awards. As a PI, he has received more than $5.8M in research funding, and he has licensed 5 technologies to local and international MedTech companies.